No Data
No Data
A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $68 to $100
Earnings Call Summary | Crinetics(CRNX.US) Q4 2024 Earnings Conference
Express News | Citizens Capital Markets Maintains Market Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $91
A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $68 to $97
Crinetics Price Target Lowered to $68 From $74 at Citi
Crinetics Pharmaceuticals: Positioned for Growth With Promising Drug Pipeline and Strong Financials